T

Theragen Etex Co Ltd
KOSDAQ:066700

Watchlist Manager
Theragen Etex Co Ltd
KOSDAQ:066700
Watchlist
Price: 3 005 KRW -0.33%
Market Cap: ₩111.6B

Net Margin

-17.3%
Current
Declining
by 16.4%
vs 3-y average of -0.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-17.3%
=
Net Income
₩-46.4B
/
Revenue
₩268.1B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-17.3%
=
Net Income
₩-46.4B
/
Revenue
₩268.1B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Theragen Etex Co Ltd
KOSDAQ:066700
110.2B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

Lower than 83% of companies in Korea
Percentile
17th
Based on 2 632 companies
17th percentile
-17.3%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Theragen Etex Co Ltd
Glance View

Market Cap
111.6B KRW
Industry
Pharmaceuticals

THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products and in the provision of genome sequencing services. The company is headquartered in Ansan, Gyeonggi-Do. The company went IPO on 2004-05-27. is a Korea-based company engaged in the industrial equipment business, healthcare and genome business and pharmaceutical business. The firm operates its business through three divisions: flat panel display (FPD) manufacturing equipment division, which provides loading and unloading systems, printed circuit board (PCB) bonding systems, battery washing lines and laser systems; healthcare and genome division engages in the provision of genome analysis services and others, and pharmaceutical division engages in the manufacture of digestive system remedies, antibiotics, remedies for fever, circulatory system remedies, respiration system remedies, treatment for chronic hepatitis, diabetes remedies, psychotropic agents, osteoporosis treatments and others.

Intrinsic Value
6 426.02 KRW
Undervaluation 53%
Intrinsic Value
Price
T
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-17.3%
=
Net Income
₩-46.4B
/
Revenue
₩268.1B
What is Theragen Etex Co Ltd's current Net Margin?

The current Net Margin for Theragen Etex Co Ltd is -17.3%, which is below its 3-year median of -0.9%.

How has Net Margin changed over time?

Over the last 3 years, Theragen Etex Co Ltd’s Net Margin has decreased from 3.5% to -17.3%. During this period, it reached a low of -17.4% on Jun 30, 2025 and a high of 12.1% on Dec 31, 2023.

Back to Top